The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Extracorporeal Membrane Oxygenation (ECMO)-Global Market Insights and Sales Trends 2024
Synopsis
The global Extracorporeal Membrane Oxygenation (ECMO) market size is expected to reach US$ 360 million by 2029, growing at a CAGR of 3.2% from 2023 to 2029. The market is mainly driven by the significant applications of Extracorporeal Membrane Oxygenation (ECMO) in various end use industries. The expanding demands from the Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR),, are propelling Extracorporeal Membrane Oxygenation (ECMO) market. Veno-Arterial, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Arterio-Venous segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Extracorporeal Membrane Oxygenation (ECMO) market, driven by demand from China, the second largest economy with some signs of stabilising, the Extracorporeal Membrane Oxygenation (ECMO) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Extracorporeal Membrane Oxygenation (ECMO), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Extracorporeal Membrane Oxygenation (ECMO) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Extracorporeal Membrane Oxygenation (ECMO) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Extracorporeal Membrane Oxygenation (ECMO) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Extracorporeal Membrane Oxygenation (ECMO) covered in this report include MAQUET, Microport, XENIOS, LivaNova, Medtronic, Terumo Cardiovascular and Nipro, etc.
The global Extracorporeal Membrane Oxygenation (ECMO) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
MAQUET
Microport
XENIOS
LivaNova
Medtronic
Terumo Cardiovascular
Nipro
Global Extracorporeal Membrane Oxygenation (ECMO) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Extracorporeal Membrane Oxygenation (ECMO) market, Segment by Type:
Veno-Arterial
Arterio-Venous
Veno-Venous
Global Extracorporeal Membrane Oxygenation (ECMO) market, by Application
Respiratory
Cardiac
Extracorporeal Cardiopulmonary Resuscitation (ECPR)
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Extracorporeal Membrane Oxygenation (ECMO) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Extracorporeal Membrane Oxygenation (ECMO) market size is expected to reach US$ 360 million by 2029, growing at a CAGR of 3.2% from 2023 to 2029. The market is mainly driven by the significant applications of Extracorporeal Membrane Oxygenation (ECMO) in various end use industries. The expanding demands from the Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR),, are propelling Extracorporeal Membrane Oxygenation (ECMO) market. Veno-Arterial, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Arterio-Venous segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Extracorporeal Membrane Oxygenation (ECMO) market, driven by demand from China, the second largest economy with some signs of stabilising, the Extracorporeal Membrane Oxygenation (ECMO) market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Extracorporeal Membrane Oxygenation (ECMO), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Extracorporeal Membrane Oxygenation (ECMO) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Extracorporeal Membrane Oxygenation (ECMO) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Extracorporeal Membrane Oxygenation (ECMO) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Extracorporeal Membrane Oxygenation (ECMO) covered in this report include MAQUET, Microport, XENIOS, LivaNova, Medtronic, Terumo Cardiovascular and Nipro, etc.
The global Extracorporeal Membrane Oxygenation (ECMO) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
MAQUET
Microport
XENIOS
LivaNova
Medtronic
Terumo Cardiovascular
Nipro
Global Extracorporeal Membrane Oxygenation (ECMO) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Extracorporeal Membrane Oxygenation (ECMO) market, Segment by Type:
Veno-Arterial
Arterio-Venous
Veno-Venous
Global Extracorporeal Membrane Oxygenation (ECMO) market, by Application
Respiratory
Cardiac
Extracorporeal Cardiopulmonary Resuscitation (ECPR)
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Extracorporeal Membrane Oxygenation (ECMO) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Extracorporeal Membrane Oxygenation (ECMO)
1.1 Extracorporeal Membrane Oxygenation (ECMO) Market Overview
1.1.1 Extracorporeal Membrane Oxygenation (ECMO) Product Scope
1.1.2 Extracorporeal Membrane Oxygenation (ECMO) Market Status and Outlook
1.2 Global Extracorporeal Membrane Oxygenation (ECMO) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Extracorporeal Membrane Oxygenation (ECMO) Market Size by Region (2018-2029)
1.4 Global Extracorporeal Membrane Oxygenation (ECMO) Historic Market Size by Region (2018-2023)
1.5 Global Extracorporeal Membrane Oxygenation (ECMO) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Extracorporeal Membrane Oxygenation (ECMO) Market Size (2018-2029)
1.6.1 North America Extracorporeal Membrane Oxygenation (ECMO) Market Size (2018-2029)
1.6.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size (2018-2029)
1.6.3 Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Market Size (2018-2029)
1.6.4 Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size (2018-2029)
1.6.5 Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Market Size (2018-2029)
2 Extracorporeal Membrane Oxygenation (ECMO) Market by Type
2.1 Introduction
2.1.1 Veno-Arterial
2.1.2 Arterio-Venous
2.1.3 Veno-Venous
2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Historic Market Size by Type (2018-2023)
2.2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Extracorporeal Membrane Oxygenation (ECMO) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Extracorporeal Membrane Oxygenation (ECMO) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Revenue Breakdown by Type (2018-2029)
3 Extracorporeal Membrane Oxygenation (ECMO) Market Overview by Application
3.1 Introduction
3.1.1 Respiratory
3.1.2 Cardiac
3.1.3 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
3.2 Global Extracorporeal Membrane Oxygenation (ECMO) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Extracorporeal Membrane Oxygenation (ECMO) Historic Market Size by Application (2018-2023)
3.2.2 Global Extracorporeal Membrane Oxygenation (ECMO) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Extracorporeal Membrane Oxygenation (ECMO) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Extracorporeal Membrane Oxygenation (ECMO) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Extracorporeal Membrane Oxygenation (ECMO) Revenue Breakdown by Application (2018-2029)
4 Extracorporeal Membrane Oxygenation (ECMO) Competition Analysis by Players
4.1 Global Extracorporeal Membrane Oxygenation (ECMO) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Extracorporeal Membrane Oxygenation (ECMO) as of 2022)
4.3 Date of Key Players Enter into Extracorporeal Membrane Oxygenation (ECMO) Market
4.4 Global Top Players Extracorporeal Membrane Oxygenation (ECMO) Headquarters and Area Served
4.5 Key Players Extracorporeal Membrane Oxygenation (ECMO) Product Solution and Service
4.6 Competitive Status
4.6.1 Extracorporeal Membrane Oxygenation (ECMO) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 MAQUET
5.1.1 MAQUET Profile
5.1.2 MAQUET Main Business
5.1.3 MAQUET Extracorporeal Membrane Oxygenation (ECMO) Products, Services and Solutions
5.1.4 MAQUET Extracorporeal Membrane Oxygenation (ECMO) Revenue (US$ Million) & (2018-2023)
5.1.5 MAQUET Recent Developments
5.2 Microport
5.2.1 Microport Profile
5.2.2 Microport Main Business
5.2.3 Microport Extracorporeal Membrane Oxygenation (ECMO) Products, Services and Solutions
5.2.4 Microport Extracorporeal Membrane Oxygenation (ECMO) Revenue (US$ Million) & (2018-2023)
5.2.5 Microport Recent Developments
5.3 XENIOS
5.3.1 XENIOS Profile
5.3.2 XENIOS Main Business
5.3.3 XENIOS Extracorporeal Membrane Oxygenation (ECMO) Products, Services and Solutions
5.3.4 XENIOS Extracorporeal Membrane Oxygenation (ECMO) Revenue (US$ Million) & (2018-2023)
5.3.5 LivaNova Recent Developments
5.4 LivaNova
5.4.1 LivaNova Profile
5.4.2 LivaNova Main Business
5.4.3 LivaNova Extracorporeal Membrane Oxygenation (ECMO) Products, Services and Solutions
5.4.4 LivaNova Extracorporeal Membrane Oxygenation (ECMO) Revenue (US$ Million) & (2018-2023)
5.4.5 LivaNova Recent Developments
5.5 Medtronic
5.5.1 Medtronic Profile
5.5.2 Medtronic Main Business
5.5.3 Medtronic Extracorporeal Membrane Oxygenation (ECMO) Products, Services and Solutions
5.5.4 Medtronic Extracorporeal Membrane Oxygenation (ECMO) Revenue (US$ Million) & (2018-2023)
5.5.5 Medtronic Recent Developments
5.6 Terumo Cardiovascular
5.6.1 Terumo Cardiovascular Profile
5.6.2 Terumo Cardiovascular Main Business
5.6.3 Terumo Cardiovascular Extracorporeal Membrane Oxygenation (ECMO) Products, Services and Solutions
5.6.4 Terumo Cardiovascular Extracorporeal Membrane Oxygenation (ECMO) Revenue (US$ Million) & (2018-2023)
5.6.5 Terumo Cardiovascular Recent Developments
5.7 Nipro
5.7.1 Nipro Profile
5.7.2 Nipro Main Business
5.7.3 Nipro Extracorporeal Membrane Oxygenation (ECMO) Products, Services and Solutions
5.7.4 Nipro Extracorporeal Membrane Oxygenation (ECMO) Revenue (US$ Million) & (2018-2023)
5.7.5 Nipro Recent Developments
6 North America
6.1 North America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Extracorporeal Membrane Oxygenation (ECMO) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Extracorporeal Membrane Oxygenation (ECMO) Market Dynamics
11.1 Extracorporeal Membrane Oxygenation (ECMO) Industry Trends
11.2 Extracorporeal Membrane Oxygenation (ECMO) Market Drivers
11.3 Extracorporeal Membrane Oxygenation (ECMO) Market Challenges
11.4 Extracorporeal Membrane Oxygenation (ECMO) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
